A Study to Evaluate GBT021601-012 Single Dose and Multiple Dose in Participants With Sickle Cell Disease (SCD)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
Korea Post Marketing Surveillance (PMS) Study of Talzenna®
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study to Evaluate Clinical Real World Outcomes of Lorlatinib After Alectinib in ALK-Positive NSCLC Japanese Patients
- Status
- COMPLETED
- Phase
- N/A
PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2)
- Status
- UNKNOWN
- Phase
- PHASE4
Study to Assess the Pharmacokinetics, Safety and Tolerability of Aztreonam-Avibactam in Healthy Chinese Participants.
- Status
- COMPLETED
- Phase
- PHASE1
The Incidence of Venous Thromboembolism in Atopic Dermatitis
- Status
- COMPLETED
- Phase
- N/A
Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo
- Status
- COMPLETED
- Phase
- N/A
Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer for Prazosin Hydrochloride Capsules
- Status
- COMPLETED
- Phase
- PHASE1
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- Status
- RECRUITING
- Phase
- PHASE3
Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir
- Status
- COMPLETED
- Phase
- PHASE1
Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.
- Status
- COMPLETED
- Phase
- PHASE3
Mental Health Associations With Vitiligo
- Status
- COMPLETED
- Phase
- N/A
Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)
- Status
- UNKNOWN
- Phase
- PHASE3
Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises
- Status
- COMPLETED
- Phase
- PHASE3
IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.
- Status
- UNKNOWN
- Phase
- PHASE2
Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD
- Status
- TERMINATED
- Phase
- N/A
Retrospective Real World Oxbryta® Data Collection and Analysis Study
- Status
- COMPLETED
- Phase
- N/A